Antimicrobial Resistance Drives Diagnostics And Policy Shifts

Antimicrobial resistance is reducing available treatments, causing about 2.8 million antibiotic-resistant illnesses annually in the U.S. and nearly 5 million global deaths. A microbiologist outlines four near-term trends — faster point-of-care diagnostics, nontraditional therapies such as phages and CRISPR, environmental One Health transmission, and policy measures like the PASTEUR Act’s proposed $3 billion subscription model — that will shape responses.